n-methyladenosine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Li, M; Wu, J; Zhao, G | 1 |
| Chaim, IA; Einstein, JM; Li, H; Madrigal, AA; Meena, JK; Neill, NJ; Nussbacher, JK; Perelis, M; Shankar, A; Tankka, AT; Tyagi, S; Westbrook, TF; Yee, BA; Yeo, GW | 1 |
2 other study(ies) available for n-methyladenosine and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer.
Topics: Adenosine; Adult; Aged; Biomarkers, Tumor; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Kaplan-Meier Estimate; Middle Aged; Models, Genetic; Prognosis; RNA, Long Noncoding; ROC Curve; Triple Negative Breast Neoplasms | 2021 |
Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer.
Topics: Adenosine; Animals; Breast Neoplasms; Cell Death; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Mice, Nude; Mice, Transgenic; Protein Biosynthesis; RNA-Binding Proteins; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2021 |